Last update 20 Mar 2025

Asparaginase

Overview

Basic Info

Drug Type
Enzyme
Synonyms
Asparaginase (Recombinant), Asparaginase (USAN), Asparaginase Erwinia chrysanthemi (USAN)
+ [11]
Target
Action
inhibitors
Mechanism
ASN inhibitors(Asparagine inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
European Union (14 Jan 2016),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute Lymphoblastic Leukemia
Iceland
14 Jan 2016
Acute Lymphoblastic Leukemia
European Union
14 Jan 2016
Acute Lymphoblastic Leukemia
Liechtenstein
14 Jan 2016
Acute Lymphoblastic Leukemia
Norway
14 Jan 2016
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Burkitt LymphomaPhase 2
Brazil
26 Apr 2019
Precursor B-Cell Lymphoblastic Leukemia-LymphomaPhase 2
Brazil
26 Apr 2019
Acute Lymphoblastic LeukemiaPhase 2
Netherlands
01 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
502
(Hematology/Oncology Specialists)
iyhmmtwrjq(dnohiuacht) = ztyqyllpke ooljhiycgg (vdzexggfft )
Negative
14 May 2024
Phase 3
1,645
hwstpdkzbq(pfrquohuys) = rpezhnawsv guuhbpbleq (mceajxfisi, aplterqsco - odvwhumxdg)
-
07 Jul 2020
hwstpdkzbq(pfrquohuys) = mwabnfomkd guuhbpbleq (mceajxfisi, mznwsuqogl - qcolnwllgm)
Not Applicable
-
tlnkbjrvdm(odjxlqfysn) = twvqmrglde uwlazhbofm (vxixeyttua )
Positive
14 May 2020
Not Applicable
135
(rmavkmjqzg) = qgwrzdbxci ljrjmvsgin (wphcfarlhs )
Negative
14 May 2020
Phase 3
1,070
(Arm A: Standard Arm - No GMTZ, AML Pts w/Out Down Syndrome)
jeduprlbkt(arvrpuvfhb) = xvlzqorcqt hohdvngiip (ncbhedvgqr, biakbukdop - koyojptonz)
-
13 Jan 2015
jeduprlbkt(arvrpuvfhb) = unjvzmfnko hohdvngiip (ncbhedvgqr, lyebqojgwh - zqvgnfjnjq)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free